H.R.2823 - Federal Government
To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, to amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements, and to amend such Code to deny any deduction for direct-to-consumer advertisements of qualified prescription drugs for a two-year period. |
Sponsor introductory remarks on measure. (CR E1375)06/21/2007
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.06/21/2007- Referred to House Ways and Means06/21/2007
- Referred to House Energy and Commerce06/21/2007
- Referred to the Subcommittee on Health.06/21/2007
ok 
cancel